On March 1st, firms were given an effective six month grace period to achieve full compliance with the non-cleared variation margin rules. In what seems like the blink of an eye, we’re now a mere ten days out from the day your firm needs to be compliant....
On March 1st, firms were given an effective six month grace period to achieve full compliance with the non-cleared variation margin rules. In what seems like the blink of an eye, we’re now a mere ten days out from the day your firm needs to be compliant.
Couple the time pressure with existing business demands and the need for an easy to implement collateral management solution becomes more apparent than ever.
Gain efficiency over your collateral management process with triResolve Margin.
Join this webinar to discover:
triResolve QuickPort is the free and efficient way to respond to portfolio reconciliation requests from your OTC counterparties.
Join this webinar to discover:
Whether you are caught in the new margin regulation for OTC derivative trading or not, the pricing implications affect your daily trading.
Join this webinar to discover:
As of January 3rd 2018 FX forwards will need to be collateralised under the European margin rules.
We have created a brief Q&A which highlights the key components of the regulation, what it means for your firm and how you can achieve compliance.
JOHN LOTHIAN | Sometimes the machine needs a reboot. Such is the case with NEX Group, the former ICAP group minus the ICAP voice brokerage business.
Post-trade business reorganises with a focus on cost-cutting and simplification.
Collateral management has typically been a fragmented and manual process. Join this webinar to find out how we are reinventing collateral management with triResolve Margin and get a latest update of the service in a live demo.
Accuracy of regulatory trade reporting is still a problem for the industry. Join this event to find out how triResolve can help align the reported data in one central place and learn about our cutting-edge new functionality in a live demo.
Three firms have signed up to use the tool, which calculates MVA across 100,000 scenarios.
If you are an Asset Manager, Hedge Fund Manager or Corporate Treasurer, please join us and discover:
Today’s OTC derivative trades no longer rely on a market quote but include CVA, DVA and FVA in the pricing calculation. This means that the counterparty’s creditworthiness, your cost of funding and your collateral agreements all contribute adjustments to the final price of a trade.
Error-strewn, duplicated and inconsistent – reporting of over-the-counter derivatives contracts data to trade repositories was supposed to lead to transparency and maintain global financial stability. As Jenny Nilsson, product marketing executive at triResolve, the portfolio reconciliation and reporting validation service from TriOptima, explains, that goal seems a long way off. The industry must proactively reconcile data with its counterparties and work together to ensure data accuracy.
triCalculate can help assess the cost of entering into a collateral agreement which will directly affect the pricing of an OTC derivative. As new margin rules are implemented in the US (September 2016) and Europe (Spring 2017), triCalculate can assist in the transition to a new or upgraded collateral relationship.
Recognising the importance of accuracy in public reporting, triCalculate now incorporates a mathematically sound and easy to produce methodology that splits the CVA of a netting set into a value for each of the underlying trades to accommodate new balance sheet reporting requirements.
In a bid to increase transparency and facilitate regulatory oversight of the OTC derivative market, the introduction of mandatory reporting and data repositories is well intentioned. However, despite a huge effort from the industry to report their trade data, challenges persist.
There are many opinions in the industry when it comes to calculating wrong way risk (WWR).
David White, Global Head of Sales, triResolve discusses the key challenges of the non-cleared margin rules and what TriOptima are doing to help.
Collateral management is changing, are you prepared for the new rules? View TriOptima's short film to understand the impact of the new rules and gain insight into how you can overcome the challenges.
In their continued efforts to make the financial system more stable, regulators are introducing new margin requirements for non-cleared OTC derivatives, effective 1st September 2016.
In Asia there is no one regulatory regime or universally accepted best practices criteria across the financial services landscape for OTC derivatives.
With regulatory pressures mounting and firms striving to keep costs down, Thomas Griffiths of triCalculate outlines the top 5 challenges of effectively calculating XVA.
KPMG | Is Asia Pacific ready for margin requirements for non-centrally cleared OTC derivatives?
Post-crisis regulations mandate the use of risk mitigation activities like portfolio compression, portfolio reconciliation, trade reporting, central clearing, and margin management to bring stability and transparency to the OTC derivative markets. Mireille Dyrberg, COO of TriOptima and Peter Weibel, CEO of TriOptima’s triReduce service discuss their firm’s network solution approach to solving the challenges of efficient and effective risk mitigation.
For the past several years, derivatives conferences have been all about regulation. But as Dodd-Frank, MiFID II and other global regulations move through the rulemaking phase to implementation and beyond, the focus has shifted from regulation to innovation.
Innovation, creativity and adaptability have characterised the over-the-counter derivatives industry since the first interest rate swap was executed between IBM and the World Bank in 1981. As the market for OTC derivatives grew, the need for better post-trade management also emerged, and TriOptima’s multilateral early termination service, triReduce was an early leader in addressing that need.